Additionally, biomarker investigations (blood, cerebrospinal fluid and imaging studies) may enhance our understanding of the intrinsic connections between APOE genotypes, neuropathology and motor signs in older adults with AD (e.g., to shed light onto the potential presence of alternative non-AD neuropathologies that mediate the presence of motor signs in AD). The gene discussed is APOE; the disease is Alzheimer disease.